SEARCH RESULTS

169342 RESULTS

AAB-003

THERAPEUTICS Janssen Pfizer PF-05236812 Immunotherapy (passive) Amyloid-Related Starting in September 2010, Pfizer and Jannssen AIP conducted a double-blind Phase 1 trial with an open-label extension at centers in the United States and South Korea. The adaptive trial ...

MEDI1814

THERAPEUTICS AstraZeneca Immunotherapy (passive) Amyloid-Related In February 2014, AstraZeneca started a multicenter Phase 1 trial in the United States, which is to enroll 242 people with mild to moderate Alzheimer's disease. The study will evaluate single and ...

LY3002813

THERAPEUTICS Eli Lilly & Co. N3pG-Aβ Monoclonal Antibody Immunotherapy (passive) Amyloid-Related In May 2013, Lilly started a Phase 1 study in 100 people on the spectrum of mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease ...

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE